Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher O'Connor, MDPrincipal Investigator
- Milton Packer, MDStudy ChairKOL profile →
- William F. Peacock, MDPrincipal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
163 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Ciudad Autonoma, Buenos Aires, Argentina
- Facility name not stated
Coronel Suárez, Buenos Aires, Argentina
- Facility name not stated
La Plata, Buenos Aires, Argentina
- Facility name not stated
Córdoba, Córdoba Province, Argentina
- Facility name not stated
San Vicente, Córdoba Province, Argentina
- Facility name not stated
Rosario, Santa Fe Province, Argentina
- Facility name not stated
San Miguel de Tucumán, Tucumán Province, Argentina
- Facility name not stated
Corrientes, Argentina
- Facility name not stated
Córdoba, Argentina
- Facility name not stated
Córdoba, Argentina
- Facility name not stated
Córdoba, Argentina
- Facility name not stated
Córdoba, Argentina
- Facility name not stated
Córdoba, Argentina
- Facility name not stated
San Miguel de Tucumán, Argentina
- Facility name not stated
Santa Fe, Argentina
- Facility name not stated
Santa Fe, Argentina
- Facility name not stated
Aalst, Belgium
- Facility name not stated
Kortrijk, Belgium
- Facility name not stated
Goiânia, Goiás, Brazil
- Facility name not stated
Porto Alegre, Rio Grande do Sul, Brazil
- Facility name not stated
Campinas, São Paulo, Brazil
- Facility name not stated
São José do Rio Preto, São Paulo, Brazil
- Facility name not stated
São Paulo, São Paulo, Brazil
- Facility name not stated
Halifax, Nova Scotia, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Brno, Czechia
- Facility name not stated
Brno, Czechia
- Facility name not stated
Frýdek-Místek, Czechia
- Facility name not stated
Hradec Králové, Czechia
- Facility name not stated
Olomouc, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Znojmo, Czechia
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Espoo, Finland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2012
- Primary completion
- 30 Nov 2015
- Completion
- 31 Mar 2016
- Last update posted
- 23 Oct 2018
- Registered enrollment
- 2,157
- Registry id
- NCT01661634
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.